Insider Selling: Trulieve Cannabis (NYSE:TRLV) CEO Sells $1,322,943.16 in Stock

Trulieve Cannabis Corp. (NYSE:TRLV) CEO Kim Rivers sold 139,846 shares of the company’s stock in a transaction on Thursday, June 18th. The shares were sold at an average price of $9.46, for a total value of $1,322,943.16. Following the completion of the sale, the chief executive officer owned 2,898,539 shares of the company’s stock, valued at approximately $27,420,178.94. This trade represents a 4.60% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Trulieve Cannabis Stock Down 8.9%

TRLV stock traded down $0.90 during trading hours on Monday, hitting $9.21. 4,066,680 shares of the stock traded hands, compared to its average volume of 510,400. Trulieve Cannabis Corp. has a one year low of $3.25 and a one year high of $13.28.

Analyst Ratings Changes

Separately, Weiss Ratings began coverage on shares of Trulieve Cannabis in a report on Tuesday, June 16th. They issued a “sell (d-)” rating for the company. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, Trulieve Cannabis presently has an average rating of “Sell”.

About Trulieve Cannabis

Trulieve Cannabis Corp. is a vertically integrated cannabis company focused on the cultivation, processing, and retail sale of medical and adult-use cannabis products. The company offers a range of products that may include flower, pre-rolls, concentrates, edibles, vape products, and topicals through its dispensary network and branded product portfolio.

Trulieve’s operations have been centered primarily in the United States, with a strong presence in Florida and additional markets in other states where cannabis is legally regulated.